- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neoplasms, Germ Cell and Embryonal in New Zealand
Total 15787 results
-
Memorial Sloan Kettering Cancer CenterTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedNeuroblastomaUnited States
-
Columbia UniversityTerminatedNeuroblastomaUnited States
-
Melanoma Institute AustraliaActive, not recruiting
-
TakedaCompletedMelanoma | NeoplasmsUnited States, Australia
-
Alaunos TherapeuticsCompleted
-
MimiVax, LLCTranslational Drug Development; MeritActive, not recruitingNewly Diagnosed GlioblastomaUnited States
-
IncuronCompletedGlioblastoma | Solid TumorsUnited States
-
NuvOx LLCThe AlfredCompletedGlioblastoma MultiformeAustralia
-
Memorial Sloan Kettering Cancer CenterY-mAbs TherapeuticsActive, not recruitingNeuroblastoma | High-RiskUnited States
-
Northwell HealthFeinstein Institute for Medical ResearchCompletedBrain Tumor | Glioblastoma MultiformeUnited States
-
Memorial Sloan Kettering Cancer CenterY-mAbs TherapeuticsActive, not recruiting
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompletedMelanomaAustralia, United States
-
SkylineDxRecruitingMelanomaUnited States
-
Yale UniversityCompletedMelanoma | Lung CancerUnited States
-
Abramson Cancer Center at Penn MedicineRoswell Park Cancer Institute; CARTIRecruitingNeuroendocrine Tumors | Neuroendocrine Tumor Grade 2United States
-
Nina BhardwajCancer Research Institute, New York City; Ludwig Institute for Cancer Research and other collaboratorsCompleted
-
Northwell HealthCohen Children's Medical CenterAvailableNeuroblastoma | PheochromocytomaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
Suthee RapisuwonBristol-Myers SquibbActive, not recruitingMelanoma | Ocular MelanomaUnited States
-
Callisto PharmaceuticalsCompletedNeuroendocrine CarcinomaUnited States
-
Synta Pharmaceuticals Corp.TerminatedMelanomaUnited States, Spain, Canada, Australia, Germany, Puerto Rico, Romania, United Kingdom
-
Eli Lilly and CompanyCompletedMetastatic MelanomaAustralia, United States
-
NanoPharmaceuticals LLCRecruiting
-
The New York Eye Cancer CenterGenentech, Inc.CompletedRadiation Retinopathy | Choroidal MelanomaUnited States
-
Ludwig Institute for Cancer ResearchCancer Research Institute, NY, USATerminatedNY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaUnresectable or Metastatic MelanomaUnited States, Australia
-
Cascadian Therapeutics Inc.TerminatedAdvanced BRAF-mutant CancersUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMelanoma | Solid Tumor | Metastatic Melanoma | NeoplasmUnited States, United Kingdom
-
University Hospital, EssenActive, not recruiting
-
Novartis PharmaceuticalsCompletedBRAF Positive Metastatic MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
Memorial Sloan Kettering Cancer CenterNo longer available
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance, Germany, Italy, Sweden, United States, Australia, Canada, United Kingdom, Netherlands, Switzerland, New Zealand, Israel
-
GlaxoSmithKlineCompleted
-
PfizerCompletedGlioblastomaSouth Africa, Italy, Russian Federation, United States, Canada, Germany, Australia, Austria, Croatia, Czech Republic, France, India, Spain
-
Bristol-Myers SquibbCompletedMelanomaFrance, Italy, United States, Germany, Canada, Denmark
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCActive, not recruitingGlioblastomaUnited States
-
Precision Life Sciences GroupCompletedGlioblastoma MultiformeUnited States
-
Nina BhardwajMemorial Sloan Kettering Cancer Center; NYU Langone Health; Ludwig Institute... and other collaboratorsCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
Weill Medical College of Cornell UniversityWilliam Rhodes Center for GlioblastomaRecruiting
-
Bristol-Myers SquibbCompletedMetastatic Melanoma | Unresectable MelanomaUnited States, France
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingGlioblastomaUnited States
-
Lytix Biopharma ASLaboratory Corporation of America; OWLActive, not recruitingAdvanced MelanomaUnited States, Spain, France, Norway
-
Bristol-Myers SquibbCompletedMelanomaBelgium, Brazil, United States, Canada, Spain, Greece, France, United Kingdom, Australia, Italy, Austria, Switzerland, Germany, Israel, Russian Federation, Romania, Czechia, Poland, New Zealand
-
New York State Psychiatric InstituteTerminatedGlioblastomaUnited States
-
National Cancer Institute (NCI)WithdrawnStage IV Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
ImmunityBio, Inc.CompletedGlioblastomaUnited States